Search results
AbbVie Outlook: Why Humira Biosimilars Won't Undo Huge Sales
Investor's Business Daily· 2 hours agoFears that Humira biosimilars will erode AbbVie's top line are overblown, an analyst said Monday as...
Abbvie Inc (ABBV) Becoming More Attractive for Investors – Knox Daily
Knox Daily· 15 hours agoPrice Performance Review of ABBV On Friday, Abbvie Inc [NYSE:ABBV] saw its stock fall -4.58% to $159.62. Over the last five days, the stock< ...
Why AbbVie Stock Stumbled Today Despite the Earnings Beat
Motley Fool via Yahoo Finance· 3 days agoThe company even upped its full-year profit outlook. But AbbVie stock fell all the same, closing...
BMO cuts Abbvie stock PT on lower revenue outlook for Vraylar, Humira concerns By Investing.com
Investing.com· 8 hours agoOn Monday, BMO (TSX:BMO) Capital Markets adjusted its outlook onAbbvie (NYSE:ABBV), a...
Barclays lowers AbbVie shares target on Humira sales erosion concerns By Investing.com
Investing.com· 12 hours agoOn Monday, Barclays made an adjustment to its outlook on AbbVie (NYSE:ABBV) shares, reducing the...
Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition By Investing.com
Investing.com· 4 hours agoThe earnings call also marked a significant leadership transition, with CEO Rick Gonzalez announcing...
Better Dividend Stock: AbbVie or Johnson & Johnson?
Motley Fool via Yahoo Finance· 2 days agoThe Motley Fool has positions in and recommends Abbott Laboratories. The Motley Fool recommends Johnson & Johnson. The Motley Fool has a disclosure...
AbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates
Zacks via Yahoo Finance· 3 days agoAbbVie (ABBV) delivered earnings and revenue surprises of 2.21% and 2.65%, respectively, for the...
AbbVie Is 'Firing On All Cylinders,' But Its Stock Isn't
Investor's Business Daily· 3 days agoShares tumbled despite a first-quarter beat and earnings guidance increase.
Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth
Zacks via Yahoo Finance· 6 days agoLilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings...